Drugs Made In America Acquisition II Corp.
DMIIU- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002040475
No open-market purchases or sales by Drugs Made In America Acquisition II Corp. insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $35.0M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Drugs Made In America Acquisition II Corp. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −3 vs. Q1 2026
- Shares held
- 3.45M
- −906.9K (−20.8%) vs. Q1 2026
- Total value
- $35.0M
- −$8.46M (−19.5%) vs. Q1 2026
- New holders
- 0
- 1 more added
- Sold out
- 3
- 3 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMIIU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 11 | $35.0M |
| Q1 2026 | 14 | $43.5M |
| Q4 2025 | 30 | $116.0M |
| Q3 2025 | 75 | $458.1M |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Drugs Made In America Acquisition II Corp.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| LMR Partners LLP | 2,000,000 | $20.3M | 0.15% | 00.0% | Unchanged |
| Westchester Capital Management, LLC | 502,914 | $5.11M | 0.26% | 00.0% | Unchanged |
| Verition Fund Management LLC | 250,000 | $2.54M | 0.02% | 00.0% | Unchanged |
| BlueCrest Capital Management Ltd | 250,000 | $2.54M | 0.11% | 00.0% | Unchanged |
| Walleye Capital LLC | 100,000 | $1.02M | 0.00% | 00.0% | Unchanged |
| L1 Global Manager Pty Ltd | 100,000 | $1.02M | 0.82% | 00.0% | Unchanged |
| Readystate Asset Management LP | 100,000 | $1.02M | 0.04% | 00.0% | Unchanged |
| HRT Financial LP | 99,725 | $1.01M | 0.00% | −275−0.3% | Reduced |
| Rangeley Capital, LLC | 32,551 | $330.7K | 0.31% | −23,061−41.5% | Reduced |
| Clear Street Group Inc. | 8,084 | $82.1K | 0.00% | −158,558−95.1% | Reduced |
| UBS Group AG | 1,765 | $17.9K | 0.00% | +2+0.1% | Added |
| TIG Advisors, LLC | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Kepos Capital LP | 0 | $0 | 0.00% | −210,000−100.0% | Sold out |
| Robinson Capital Management, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |